Suggested Topics within your search.
Search alternatives:
drugs » drug (Expand Search)
technologies » technology (Expand Search)
Showing 1 - 40 results of 294 for search 'Canadian Agency for Drugs and Technologies in Health,', query time: 0.19s Refine Results
  1. 1
    Patient group input submissions. Ocrelizumab (Ocrevus) (Hoffmann-La Roche Limited).

    Patient group input submissions. Ocrelizumab (Ocrevus) (Hoffmann-La Roche Limited).

    Published 2017
    “…Canadian Agency for Drugs and Technologies in Health,…”
    Get full text
    Full text
    Electronic eBook
    Save to List
    Saved in:
  2. 2
    CADTH Canadian Drug Expert Committee final recommendation. Mifepristone and misoprostol (Mifegymiso -- Celopharma Inc.) : indication: medical termination of pregnancy.

    CADTH Canadian Drug Expert Committee final recommendation. Mifepristone and misoprostol (Mifegymiso -- Celopharma Inc.) : indication: medical termination of pregnancy.

    Published 2017
    “…Canadian Agency for Drugs and Technologies in Health,…”
    Get full text
    Full text
    Electronic eBook
    Save to List
    Saved in:
  3. 3
    Pharmacoeconomic review report. Mifepristone and misoprostol (Mifegymiso).

    Pharmacoeconomic review report. Mifepristone and misoprostol (Mifegymiso).

    Published 2017
    “…Canadian Agency for Drugs and Technologies in Health,…”
    Get full text
    Full text
    Electronic eBook
    Save to List
    Saved in:
  4. 4
    Clinical review report. Mifepristone and misoprostol (Mifegymiso).

    Clinical review report. Mifepristone and misoprostol (Mifegymiso).

    Published 2017
    “…Canadian Agency for Drugs and Technologies in Health,…”
    Get full text
    Full text
    Electronic eBook
    Save to List
    Saved in:
  5. 5
    CADTH Canadian Drug Expert Committee final recommendation. Sarilumab (Kevzara -- Sanofi Genzyme) : indication: rheumatoid arthritis.

    CADTH Canadian Drug Expert Committee final recommendation. Sarilumab (Kevzara -- Sanofi Genzyme) : indication: rheumatoid arthritis.

    Published 2017
    “…Canadian Agency for Drugs and Technologies in Health,…”
    Get full text
    Full text
    Electronic eBook
    Save to List
    Saved in:
  6. 6
    Clinical review report. Sofosbuvir/Velpatasvir/Voxilaprevir (Vosevi) (Gilead Sciences Canada, Inc.)

    Clinical review report. Sofosbuvir/Velpatasvir/Voxilaprevir (Vosevi) (Gilead Sciences Canada, Inc.)

    Version: final.
    Published 2018
    “…Canadian Agency for Drugs and Technologies in Health,…”
    Get full text
    Full text
    Electronic eBook
    Save to List
    Saved in:
  7. 7
    Clinical review report. Apomorphine (Movapo) (Paladin Labs, Inc.)

    Clinical review report. Apomorphine (Movapo) (Paladin Labs, Inc.)

    Published 2018
    “…Canadian Agency for Drugs and Technologies in Health,…”
    Get full text
    Full text
    Electronic eBook
    Save to List
    Saved in:
  8. 8
    Clinical review report. Cysteamine delayed-release capsules (Procysbi) Horizon Pharma Ireland Ltd.

    Clinical review report. Cysteamine delayed-release capsules (Procysbi) Horizon Pharma Ireland Ltd.

    Version: final.
    Published 2018
    “…Canadian Agency for Drugs and Technologies in Health,…”
    Get full text
    Full text
    Electronic eBook
    Save to List
    Saved in:
  9. 9
    Pharmacoeconomic review report. Empagliflozin and Metformin fixed-dose combination (Synjardy).

    Pharmacoeconomic review report. Empagliflozin and Metformin fixed-dose combination (Synjardy).

    Published 2017
    “…Canadian Agency for Drugs and Technologies in Health,…”
    Get full text
    Full text
    Electronic eBook
    Save to List
    Saved in:
  10. 10
    Sarilumab (Kevzara).

    Sarilumab (Kevzara).

    Published 2017
    “…Canadian Agency for Drugs and Technologies in Health,…”
    Get full text
    Full text
    Electronic eBook
    Save to List
    Saved in:
  11. 11
    Clinical review report. Dolutegravir (Tivicay).

    Clinical review report. Dolutegravir (Tivicay).

    Published 2014
    “…Canadian Agency for Drugs and Technologies in Health,…”
    Get full text
    Full text
    Electronic eBook
    Save to List
    Saved in:
  12. 12
    Clinical review report. Tocilizumab (Actemra) (Hoffmann-La Roche Limited).

    Clinical review report. Tocilizumab (Actemra) (Hoffmann-La Roche Limited).

    Published 2018
    “…Canadian Agency for Drugs and Technologies in Health,…”
    Get full text
    Full text
    Electronic eBook
    Save to List
    Saved in:
  13. 13
    Clinical review report. Guselkumab (Tremfya) (Janssen Inc.)

    Clinical review report. Guselkumab (Tremfya) (Janssen Inc.)

    Version: final.
    Published 2018
    “…Canadian Agency for Drugs and Technologies in Health,…”
    Get full text
    Full text
    Electronic eBook
    Save to List
    Saved in:
  14. 14
    Thromboelastography or rotational thromboelastography for trauma : a review of the clinical and cost-effectiveness and guidelines

    Thromboelastography or rotational thromboelastography for trauma : a review of the clinical and cost-effectiveness and guidelines by MacDonald, Erika, Severn, Melissa

    Version 1.0.
    Published 2017
    “…Canadian Agency for Drugs and Technologies in Health,…”
    Get full text
    Full text
    Electronic eBook
    Save to List
    Saved in:
  15. 15
    Intensive day treatment programs for mental health treatment : a review of clinical effectiveness, cost- effectiveness, and guidelines

    Intensive day treatment programs for mental health treatment : a review of clinical effectiveness, cost- effectiveness, and guidelines by Thompson, Wade, active 2017, Adcock, Lorna

    Version 1.0.
    Published 2017
    “…Canadian Agency for Drugs and Technologies in Health,…”
    Get full text
    Full text
    Electronic eBook
    Save to List
    Saved in:
  16. 16
    BRAF targeted therapy for patients with melanoma and active brain metastases : a review of clinical effectiveness

    BRAF targeted therapy for patients with melanoma and active brain metastases : a review of clinical effectiveness by Ho, Chuong, Adcock, Lorna

    Version 1.0.
    Published 2017
    “…Canadian Agency for Drugs and Technologies in Health,…”
    Get full text
    Full text
    Electronic eBook
    Save to List
    Saved in:
  17. 17
    PRECICE intramedullary limb lengthening system : a review of clinical effectiveness

    PRECICE intramedullary limb lengthening system : a review of clinical effectiveness by Young, Calvin (Clinical researcher), Adcock, Lorna

    Published 2017
    “…Canadian Agency for Drugs and Technologies in Health,…”
    Get full text
    Full text
    Electronic eBook
    Save to List
    Saved in:
  18. 18
    Manual therapy for recent-onset or persistent neck pain : a review of clinical effectiveness and guidelines

    Manual therapy for recent-onset or persistent neck pain : a review of clinical effectiveness and guidelines by Kanga, Ismat, Severn, Melissa

    Version 1.0.
    Published 2017
    “…Canadian Agency for Drugs and Technologies in Health,…”
    Get full text
    Full text
    Electronic eBook
    Save to List
    Saved in:
  19. 19
    Adapted or tailored psychological interventions for treating women with mental illness : a review of clinical effectiveness and guidelines

    Adapted or tailored psychological interventions for treating women with mental illness : a review of clinical effectiveness and guidelines by Williams, D. (Dinsie), Mierzwinski-Urban, Monika

    Version: 1.0.
    Published 2017
    “…Canadian Agency for Drugs and Technologies in Health,…”
    Get full text
    Full text
    Electronic eBook
    Save to List
    Saved in:
  20. 20
    Rigid dressings for edema management for leg amputation : a review of clinical and cost-effectiveness

    Rigid dressings for edema management for leg amputation : a review of clinical and cost-effectiveness by Banerjee, Srabani, Adcock, Lorna

    Version: 1.0.
    Published 2017
    “…Canadian Agency for Drugs and Technologies in Health,…”
    Get full text
    Full text
    Electronic eBook
    Save to List
    Saved in:
  21. 21
    Imiquimod for the treatment of basal cell or squamous cell carcinoma : a review of clinical effectiveness and cost-effectiveness

    Imiquimod for the treatment of basal cell or squamous cell carcinoma : a review of clinical effectiveness and cost-effectiveness by Banerjee, Srabani, Kaunelis, David

    Version: 1.0.
    Published 2017
    “…Canadian Agency for Drugs and Technologies in Health,…”
    Get full text
    Full text
    Electronic eBook
    Save to List
    Saved in:
  22. 22
    Orthodontic treatment for the management of pain or impacted teeth in patients with malocclusion : a review of clinical effectiveness and guidelines

    Orthodontic treatment for the management of pain or impacted teeth in patients with malocclusion : a review of clinical effectiveness and guidelines by Tran, Khai, active 2010, Picheca, Lory

    Version 1.0.
    Published 2017
    “…Canadian Agency for Drugs and Technologies in Health,…”
    Get full text
    Full text
    Electronic eBook
    Save to List
    Saved in:
  23. 23
    Off-label use of intravenous immunoglobulin for recurrent spontaneous abortion : a review of clinical effectiveness

    Off-label use of intravenous immunoglobulin for recurrent spontaneous abortion : a review of clinical effectiveness by Khangura, Sara, Visintini, Sarah

    Published 2018
    “…Canadian Agency for Drugs and Technologies in Health,…”
    Get full text
    Full text
    Electronic eBook
    Save to List
    Saved in:
  24. 24
    Indwelling voice prostheses for adults following laryngectomy : a review of clinical effectiveness, cost-effectiveness, and guidelines

    Indwelling voice prostheses for adults following laryngectomy : a review of clinical effectiveness, cost-effectiveness, and guidelines by Wells, Charlotte (Clinical reviewer), Adcock, Lorna

    Version 1.0.
    Published 2017
    “…Canadian Agency for Drugs and Technologies in Health,…”
    Get full text
    Full text
    Electronic eBook
    Save to List
    Saved in:
  25. 25
    E-therapy interventions for the treatment of post-traumatic stress disorder : a review of clinical evidence

    E-therapy interventions for the treatment of post-traumatic stress disorder : a review of clinical evidence by Banerjee, Srabani, Severn, Melissa

    Version 1.0.
    Published 2018
    “…Canadian Agency for Drugs and Technologies in Health,…”
    Get full text
    Full text
    Electronic eBook
    Save to List
    Saved in:
  26. 26
    CADTH Canadian drug expert committee recommendation. Latanoprost (Monoprost -- Laboratoires Thea) : indication : glaucoma and ocular hypertension.

    CADTH Canadian drug expert committee recommendation. Latanoprost (Monoprost -- Laboratoires Thea) : indication : glaucoma and ocular hypertension.

    Version 1.0.
    Published 2018
    “…Canadian Agency for Drugs and Technologies in Health,…”
    Get full text
    Full text
    Electronic eBook
    Save to List
    Saved in:
  27. 27
    CADTH Canadian Drug Expert Committee recommendation. Nitisinone (MDK-Nitisinone -- mendeliKABs inc.) : indication : the treatment of adult and pediatric patients with hereditary tyrosinemia type 1 (HT-1) in combination with dietary restriction of tyrosine and phenylalanine.

    CADTH Canadian Drug Expert Committee recommendation. Nitisinone (MDK-Nitisinone -- mendeliKABs inc.) : indication : the treatment of adult and pediatric patients with hereditary ty...

    Version 1.0.
    Published 2018
    “…Canadian Agency for Drugs and Technologies in Health,…”
    Get full text
    Full text
    Electronic eBook
    Save to List
    Saved in:
  28. 28
    Fetal scalp lactate testing during intrapartum pregnancy with abnormal fetal heart rate : a review of clinical effectiveness, cost-effectiveness, and guidelines

    Fetal scalp lactate testing during intrapartum pregnancy with abnormal fetal heart rate : a review of clinical effectiveness, cost-effectiveness, and guidelines by Young, Calvin (Clinical researcher), Ryce, Andrea

    Version 1.0.
    Published 2018
    “…Canadian Agency for Drugs and Technologies in Health,…”
    Get full text
    Full text
    Electronic eBook
    Save to List
    Saved in:
  29. 29
    Guanfacine hydrochloride extended-release for attention deficit hyperactivity disorder : a review of clinical effectiveness, cost-effectiveness, and guidelines

    Guanfacine hydrochloride extended-release for attention deficit hyperactivity disorder : a review of clinical effectiveness, cost-effectiveness, and guidelines by Harricharan, Sharada, Adcock, Lorna

    Version 1.0.
    Published 2018
    “…Canadian Agency for Drugs and Technologies in Health,…”
    Get full text
    Full text
    Electronic eBook
    Save to List
    Saved in:
  30. 30
    CADTH Canadian Drug Expert Committee recommendation. Cysteamine delayed-release (Procysbi -- Horizon Pharma Ireland Ltd.) : indication : nephropathic cystinosis.

    CADTH Canadian Drug Expert Committee recommendation. Cysteamine delayed-release (Procysbi -- Horizon Pharma Ireland Ltd.) : indication : nephropathic cystinosis.

    Version 1.0.
    Published 2018
    “…Canadian Agency for Drugs and Technologies in Health,…”
    Get full text
    Full text
    Electronic eBook
    Save to List
    Saved in:
  31. 31
    CADTH Canadian Drug Expert Committee recommendation. Nusinersen (Spinraza -- Biogen Canada Inc.) : indication : treatment of 5q spinal muscular atrophy.

    CADTH Canadian Drug Expert Committee recommendation. Nusinersen (Spinraza -- Biogen Canada Inc.) : indication : treatment of 5q spinal muscular atrophy.

    Version 1.0.
    Published 2017
    “…Canadian Agency for Drugs and Technologies in Health,…”
    Get full text
    Full text
    Electronic eBook
    Save to List
    Saved in:
  32. 32
    CADTH Canadian Drug Expert Committee recommendation. Insulin degludec (Tresiba -- Novo Nordisk Canada Inc.) : indication : diabetes mellitus, types I and II.

    CADTH Canadian Drug Expert Committee recommendation. Insulin degludec (Tresiba -- Novo Nordisk Canada Inc.) : indication : diabetes mellitus, types I and II.

    Version 1.0.
    Published 2017
    “…Canadian Agency for Drugs and Technologies in Health,…”
    Get full text
    Full text
    Electronic eBook
    Save to List
    Saved in:
  33. 33
    CADTH Canadian Drug Expert Committee recommendation. Glecaprevir / Pibrentasvir (Maviret -- Abbvie Corporation) : indication : chronic hepatitis C virus infection.

    CADTH Canadian Drug Expert Committee recommendation. Glecaprevir / Pibrentasvir (Maviret -- Abbvie Corporation) : indication : chronic hepatitis C virus infection.

    Version 1.0.
    Published 2018
    “…Canadian Agency for Drugs and Technologies in Health,…”
    Get full text
    Full text
    Electronic eBook
    Save to List
    Saved in:
  34. 34
    CADTH Canadian Drug Expert Committee final recommendation. Empagliflozin / metformin hydrochloride (Synjardy -- Boehringer Ingelheim Canada Ltd.) : indication : type 2 diabetes mellitus.

    CADTH Canadian Drug Expert Committee final recommendation. Empagliflozin / metformin hydrochloride (Synjardy -- Boehringer Ingelheim Canada Ltd.) : indication : type 2 diabetes mel...

    Published 2016
    “…Canadian Agency for Drugs and Technologies in Health,…”
    Get full text
    Full text
    Electronic eBook
    Save to List
    Saved in:
  35. 35
    Pharmacoeconomic review report. Cysteamine delayed-release capsules (Procysbi), Horizon Pharma Ireland Ltd.

    Pharmacoeconomic review report. Cysteamine delayed-release capsules (Procysbi), Horizon Pharma Ireland Ltd.

    Published 2018
    “…Canadian Agency for Drugs and Technologies in Health,…”
    Get full text
    Full text
    Electronic eBook
    Save to List
    Saved in:
  36. 36
    CADTH Canadian Drug Expert Committee recommendation. Ocrelizumab (Ocrevus -- Hoffmann-La Roche Limited) : indication : treatment of adult patients with relapsing-remitting multiple sclerosis with active disease defined by clinical and imaging features.

    CADTH Canadian Drug Expert Committee recommendation. Ocrelizumab (Ocrevus -- Hoffmann-La Roche Limited) : indication : treatment of adult patients with relapsing-remitting multiple...

    Version 1.0.
    Published 2017
    “…Canadian Agency for Drugs and Technologies in Health,…”
    Get full text
    Full text
    Electronic eBook
    Save to List
    Saved in:
  37. 37
    CADTH Canadian Drug Expert Committee recommendation. Lixisenatide (Adlyxine -- Sanofi-Aventis Canada inc.) : indication : diabetes mellitus, type 2.

    CADTH Canadian Drug Expert Committee recommendation. Lixisenatide (Adlyxine -- Sanofi-Aventis Canada inc.) : indication : diabetes mellitus, type 2.

    Version 1.0.
    Published 2017
    “…Canadian Agency for Drugs and Technologies in Health,…”
    Get full text
    Full text
    Electronic eBook
    Save to List
    Saved in:
  38. 38
    CDEC final recommendation. Tiotropium bromide (Spiriva respimat -- Boehringer Ingelheim Canada Ltd.) : indication : chronic obstructive pulmonary disease.

    CDEC final recommendation. Tiotropium bromide (Spiriva respimat -- Boehringer Ingelheim Canada Ltd.) : indication : chronic obstructive pulmonary disease.

    Published 2015
    “…Canadian Agency for Drugs and Technologies in Health,…”
    Get full text
    Full text
    Electronic eBook
    Save to List
    Saved in:
  39. 39
    CDEC final recommendation. Dolutegravir (Tivicay -- ViiV Healthcare ULC) : indication : HIV infection.

    CDEC final recommendation. Dolutegravir (Tivicay -- ViiV Healthcare ULC) : indication : HIV infection.

    Published 2014
    “…Canadian Agency for Drugs and Technologies in Health,…”
    Get full text
    Full text
    Electronic eBook
    Save to List
    Saved in:
  40. 40
    CADTH CDEC final recommendation. Empagliflozin (Jardiance -- Boehringer Ingelheim (Canada) Ltd.) : indication : Type 2 Diabetes mellitus.

    CADTH CDEC final recommendation. Empagliflozin (Jardiance -- Boehringer Ingelheim (Canada) Ltd.) : indication : Type 2 Diabetes mellitus.

    Published 2015
    “…Canadian Agency for Drugs and Technologies in Health,…”
    Get full text
    Full text
    Electronic eBook
    Save to List
    Saved in:

Search Tools: